Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2516405123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Xiaolu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 77, Sweden. Hauptthemen laut MEDLINE: COVID-19, Vascular Endothelial Growth Factor A, Retinal Diseases. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Cancer Foundation, Karolinska Institute Foundation, Novo Nordisk Foundation.
Abstract (Originalsprache)
COVID-19 has been associated with high prevalences of retinal diseases in humans. However, cellular and molecular mechanisms that underlie the COVID-19-associated retinopathy remains unknown. Here, we deployed a mouse COVID-19 model to investigate the causative link between SARS-CoV-2 infection and retinopathy development. Our data showed that COVID-19-induced pulmonary hypoxia triggered systemic hypoxia and markedly augmented VEGF expression levels in the retina and plasma. High VEGF levels altered vascular structures and functions in the retina, resulting in neovascularization, vascular disorganization, and increased leakiness. We deployed a terminology of coviretinopathy to accurately describe these COVID-19-induced pathological changes in the retina. Consequently, blocking VEGF by a specific neutralizing antibody (VEGF blockade) completely ablated the COVID-19-associated vascular changes in the retina. Together, these findings provide mechanistic insights into the COVID-19-associated retinopathy and propose a therapeutic paradigm for effective treatment of coviretinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 77, Sweden.
- Center of Clinical Research, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214023, China.
- Department of Ophthalmology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214023, China.
- Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Division of Virology and Immunology, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 77, Sweden.
- School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
ORCID-Profile: Xiaolu Wang, Xu Jing, Ziheng Guo, Sofia Appelberg, Yihai Cao
Förderung
- Swedish Cancer Foundation
- Karolinska Institute Foundation
- Novo Nordisk Foundation
- Swedish Research Council
- Swedish Research Council-the National Natural Science Foundation of China joint grants
- Strategic Research Areas (SFO)-Stem Cell and Regenerative Medicine Foundation
- Horizon Europe grant-PERSEUS
- Hong Kong Centre for Cerebro-Cardiovascular Health Engineering
Zitieren
APA
Wang, X., Jing, X., Guo, Z., Long, S., Sun, X., Appelberg, S., McInerney, G. M., Adner, M., & Cao, Y. (2026). Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2516405123
Vancouver
Wang X, Jing X, Guo Z, Long S, Sun X, Appelberg S, et al. Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2516405123
BibTeX
@article{Wang2026,
author = {Wang, Xiaolu and Jing, Xu and Guo, Ziheng and Long, Siwen and Sun, Xiaoting and Appelberg, Sofia and McInerney, Gerald M and Adner, Mikael and Cao, Yihai},
title = {Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2516405123}
}
EUVIMED